Neues Eltern- und Kinder-Therapiehaus in Harburg eröffnet

asklepios klinikum harburg eltern-kind-therapiehaus lars berger

Quick Look

Das Asklepios Klinikum Harburg hat ein neues Eltern- und Kinder-Therapiehaus eröffnet, das Familien mit psychisch belasteten Kindern eine stationäre und teilstationäre Behandlung ermöglicht.
Die Bergers aus Hamburg schildern, wie die dreimonatige Therapie ihres Sohnes Lars und der Familie half, emotionale Ausbrüche zu reduzieren und den Alltag zu stabilisieren.
Das Haus behandelt Eltern und Kinder gemeinsam, um familiäre Stressspiralen zu durchbrechen.

AI-generated summary

Why It Matters

Die Familie Berger aus Hamburg litt unter den schweren emotionalen Ausbrüchen ihres Sohnes Lars, der auf Reize überreagierte und den Familienalltag stark belastete. Nachdem ambulante Therapien nicht ausreichten, entschied sich die Familie für eine dreimonatige stationäre Behandlung in der Asklepios-Klinik Harburg.

Font size

Audioplayer wird geladen

Google

Klicken Sie hier, um sich Artikel von WELT in der Google-Suche bevorzugt anzeigen zu lassen.

What to Watch

AI outlook — possibilities, not facts

Das neue Therapiehaus wird die Wartelisten für stationäre Familienbehandlungen in Hamburg verkürzen.
Likely · Within months
Weitere Asklepios-Standorte könnten das Modell des gemeinsamen Eltern-Kind-Therapiehauses nachahmen.
Possible · Within years

Open Questions

Wie hoch sind die Kosten für eine Behandlung im neuen Therapiehaus und werden sie von Krankenkassen übernommen?
Wie lange beträgt die durchschnittliche Wartezeit auf einen Platz im Therapiehaus?
Welche langfristigen Follow-up-Studien sind geplant, um die Behandlungserfolge zu evaluieren?

More and more people in Germany and around the world are using weight loss products such as GLP-1 agonists, originally developed for diabetes, now also advertised for weight loss and longevity. While studies show positive effects on the heart, kidneys and addictive behavior, experts warn of possible psychological addictions and unknown long-term consequences on the brain. The market is growing rapidly, but the abandonment rate is up to 50 percent.

Handelsblatt

3 min read

Developing·19 hours ago

Concern about medical care is increasingly influencing political attitudes

A survey by the General Practitioners Association shows growing dissatisfaction with medical care and its influence on elections. While austerity requirements give rise to fears of deterioration, a municipality in Rhineland-Palatinate is breaking new ground with a municipal practice.

Tagesschau Inland

3 min read

Developing·20 hours ago

AOK Nordost warns of an increase in sick leave due to the requirement to provide a certificate from the first day of illness

AOK Nordost estimates that requiring a certificate from the first day of illness could increase sickness rates in Mecklenburg-Western Pomerania from the current 7.5 percent to up to 8.2 percent. The basis is a comparison of sick leave data with employer information on actual absences. At the same time, the proportion of long-term illnesses in all days missed is increasing and is now around 40 percent.

Die Zeit

1 min read

Developing·yesterday

Mental illnesses lead to the most frequent absences from work in Germany

In the first half of 2026, according to DAK insurance data, mental illnesses were the most common cause of incapacity to work in Germany, with 184 days of absence per 100 insured people - an increase of nine percent compared to the previous year. Educators and social workers are particularly affected due to a lack of staff, time pressure and emotional stress. The average duration of sick leave is over five weeks and continues to rise.

Die Zeit

2 min read

Health·yesterday

Workaholism: When does commitment become a pathological addiction?

According to a study, around a tenth of the workforce in Germany works addictively. Experts like Stefan Poppelreuter explain when excessive work becomes an addiction, what warning signs exist and why professional help is important if you lose control.

Die Welt

3 min read

Health·yesterday

Breakthrough in the treatment of narcolepsy: drug oveporexton approved

The Japanese pharmaceutical company Takeda has developed a new drug against narcolepsy called Oveporexton. After approval in the USA, China and Japan, two high-quality studies now demonstrate the high effectiveness and safety of the product.

Die Zeit

1 min read

More on this topicasklepios klinikum harburg